Position history for Epoch Investment Partners, Inc.'s holdings in REGENERON PHARMACEUTICALS
Epoch Investment Partners, Inc. holds 281,335 shares of REGN (REGENERON PHARMACEUTICALS), worth $217.2M as of 2025-Q4. The position was increased (++8.6% shares). REGN represents 1.2% of Epoch Investment Partners, Inc.'s portfolio.
Current Value
$217.2M
Current Shares
281,335
Total Value Change
+$45.5M
Total Shares Change
+118,039
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 281,335 |
+8.6% |
| $217.2M |
| 1.2% |
| $773.94 |
52 |
| 2025-Q3 | Increased | 259,153 | +27.6% | $145.7M | 0.8% | $560.05 | 53 |
| 2025-Q2 | Decreased | 203,057 | -2.1% | $106.6M | 0.6% | $519.56 | 0 |
| 2025-Q1 | Increased | 207,456 | +5.2% | $131.6M | 0.7% | $634.66 | 45 |
| 2024-Q4 | Increased | 197,266 | +25.1% | $140.5M | 0.7% | $698.71 | 52 |
| 2024-Q3 | Decreased | 157,740 | -3.4% | $165.8M | 0.7% | $1,036.94 | 0 |
| 2024-Q2 | Increased | 163,296 | +57.7% | $171.6M | 0.8% | $1,045.23 | 61 |